Twelve of the 42 TNBC patients carried pathogenic variants: 7 in BRCA1 and 5 in BRCA2. Nineteen non pathogenic variants (8 in BRCA1 and 11 in BRCA2) were detected in 96 BC patients (73.8%) (Table 3). This evidence concerns the gene BRCA1 and breast cancer.